Fever-Induced Type 1 ECG Pattern of Brugada Syndrome by Lioni, Louiza et al.
Fever-Induced Type 1 ECG Pattern of 
Brugada Syndrome
Louiza Lioni, MD, George Bakosis, MD, Charalampos Kavvouras, MD, 
Konstantinos P. Letsas, MD, FESC, Antonios Sideris, MD.
A B S T R A C T
A surface electrocardiogram (ECG) on admission in a 38-year-old lady performed 
during a febrile state (38.8°C) revealed the typical coved type 1 ECG pattern of Bru-
gada syndrome. Two hours later, when the patient was afebrile, a repeat ECG failed 
to show any abnormality. A febrile state may unmask Brugada syndrome but has also 
been reported to even precipitate ventricular fibrillation. Thus, fever should be vigor-
ously treated with antipyretics in these patients. 
A 38-year-old female with a history of tobacco use presented to the emergency de-
partment with symptoms and signs of an upper respiratory infection. ECG on admission 
performed during febrile state (38.8°C) revealed the diagnostic type 1 ECG pattern 
of Brugada syndrome, a pattern characterized by coved type ST-segment elevation 
> 2 mm followed by negative T waves in the right precordial leads (V
1
 and V
2
) (Fig. 
1). Two hours later, a new ECG performed without fever failed to show any of these 
abnormalities (Fig. 2). Serum electrolytes and biochemical markers of myocardial 
damage were normal. Transthoracic echocardiography demonstrated normal wall 
motion of both ventricles with an estimated left ventricular ejection fraction of 70%. 
Ambulatory Holter ECG monitoring demonstrated low heart rate variability without 
any arrhythmias. Her past medical history was unremarkable and negative for syncope 
or family history of Brugada syndrome. The patient is under a close follow-up and she 
was counselled to use antipyretics whenever a fever develops as well as to avoid certain 
drugs that unmask the Brugada ECG pattern.1
ŏŏŏ
The Brugada syndrome is an arrhythmogenic entity that typically manifests with 
syncope or cardiac arrest due to ventricular fibrillation in individuals with structurally 
normal hearts.2,3 The SCN5A gene encoding for the cardiac sodium channel (Nav1.5) 
was the first gene linked to BS, found in 11% to 28% of Brugada syndrome probands.3,4 
Mutations in CACNA1C (Cav1.2), CACNB2b (Cavą2b), glycerol-3-phophate dehydro-
genase 1-like enzyme gene (GPD1L), SCN1B (ą1 subunit of sodium channel), KCNE3 
(MiRP), and SCN3B (ą3 subunit of sodium channel) are much more rare.4
The ECG features of Brugada syndrome are often concealed. Sodium channel 
blockers, vagotonic agents, Ą-adrenergic agonists, ą-adrenergic blockers, tricyclic 
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FEVER UNMASKING BRUGADA SYNDROME
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FIGURE 1.
FIGURE 2.
antidepressants, glucose-induced insulin secretion, fever, 
hyperkalemia, hypokalemia, hypercalcemia, alcohol and 
cocaine toxicity have been shown to unmask or modulate the 
characteristic ST-segment elevation in right precordial leads.3,4 
Previous reports have demonstrated that febrile state unmask 
or accentuate the ECG pattern of Brugada syndrome and pre-
cipitate ventricular fibrillation occurrences.5-8 At a molecular 
level, the ionic mechanisms responsible for the ECG pattern 
of Brugada syndrome have been showed to be temperature 
dependent. Dumaine et al reported an accelerated inactivation 
of the sodium current carrying the T1620M missense mutation 
at high temperatures.9 Keller et al. identified a novel SCN5A 
mutation, F1344S, in a patient with Brugada syndrome and 
fever-induced ventricular fibrillation. The mutation resulted 
in loss of sodium channel function due to shift of activation.10 
Due to the increased risk of ventricular arrhythmias during fe-
brile state regardless of the existence of a predisposing genetic 
base,11 fever should be vigorously treated with antipyretics in 
these patients. 
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